Geron Corporation

GERN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Mar 26, 2026
3 Mar 26, 2026
8-K Mar 26, 2026 8-K
SCHEDULE 13G Mar 3, 2026
S-3ASR Mar 2, 2026 S-3ASR
10-K Mar 2, 2026 10-K
8-K Feb 25, 2026 8-K
4 Feb 19, 2026
4 Feb 19, 2026
SCHEDULE 13G/A Feb 13, 2026
8-K Jan 12, 2026 8-K
8-K Jan 6, 2026 8-K
4 Jan 5, 2026
8-K Dec 16, 2025 8-K
144 Dec 15, 2025
10-Q Nov 7, 2025 10-Q
8-K Nov 5, 2025 8-K
4 Oct 20, 2025 FORM 4
3 Oct 20, 2025 FORM 3
8-K Oct 14, 2025 8-K
4 Oct 1, 2025 FORM 4
SCHEDULE 13G/A Aug 14, 2025
4 Aug 8, 2025 FORM 4
3 Aug 8, 2025 FORM 3
S-8 Aug 6, 2025 S-8
← Newer Page 2 of 59 · 1475 filings Older →